文献速递生殖医学

缩宫素拮抗逆转高水平雌激素与缩宫素对内膜蜕膜化和环氧化酶活性的影响

Oxytocin antagonism reverses the effects of high oestrogen levels and oxytocin on decidualization and cyclooxygenase activity in endometrial tissues.
PubMed 文献 · Reprod Biomed Online · 2019-06-12

该体外实验取30名接受生育治疗女性的子宫内膜活检组织及tHESC内膜细胞系,在模拟卵巢刺激的高雌二醇条件下培养,观察缩宫素受体拮抗剂阿托西班对蜕膜化指标、COX-1/2活性及PGF2α分泌的影响。结果显示高雌二醇与缩宫素均降低细胞活力和催乳素分泌、增强COX-2活性与PGF2α生成,阿托西班可逆转上述效应。

要点

  • 高雌二醇与缩宫素均降低内膜细胞活力和催乳素分泌,并增强COX-2活性与PGF2α生成。
  • 缩宫素拮抗剂阿托西班在细胞系和内膜组织中均可逆转上述效应。
  • 作者认为这可能提示胚胎移植前应用缩宫素拮抗剂支持胚胎着床的新内膜相关机制。

核心结论

  • 缩宫素拮抗剂可逆转高雌二醇和缩宫素对模拟卵巢刺激条件下子宫内膜容受性相关参数的影响。
  • 作者认为这可能指向胚胎移植前应用缩宫素拮抗剂支持胚胎着床的一种新的、与子宫内膜相关的机制。

研究设计与样本

  • 体外实验研究,子宫内膜组织经抽吸活检取自30名接受生育治疗的女性,并培养子宫内膜tHESC细胞系。
  • 研究检测高雌二醇、缩宫素及缩宫素受体拮抗剂对蜕膜化参数(细胞活力和催乳素分泌)、COX-1/2活性及PGF2α分泌的影响。
  • 采用定量聚合酶链反应(qPCR)检测OXTR和COX-2基因表达变化。

主要发现

  • 在培养子宫内膜细胞系实验中,高雌二醇和缩宫素同样限制了细胞活力。
  • 在培养子宫内膜组织中,两者均降低催乳素(蜕膜化标志物)分泌,并增强子宫内膜COX-2活性和PGF2α生成。
  • 缩宫素拮抗剂阿托西班被证实可在子宫内膜细胞系和子宫内膜组织中逆转上述效应。
  • 在同时使用缩宫素和高雌二醇的实验中,加入阿托西班的作用类似。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What is the in-vitro effect of oxytocin receptor (OTR) antagonism on parameters of receptivity in human endometrial explants and endometrial stromal cell lines cultured in oestradiol-rich conditions mimicking ovarian stimulation? DESIGN: Experimental in-vitro study on endometrial tissue explants collected by aspiration biopsy from 30 women undergoing fertility treatment and cultured endometrial tHESC cell line. The study examined the effects of high oestradiol, oxytocin and OTR antagonist on parameters of decidualization (cell viability and prolactin secretion) as well as cyclooxygenase-1/2 (COX-1/2) activity and prostaglandin F2α (PGF2α) secretion. Changes in expression of OXTR and COX-2 genes were examined using quantitative polymerase chain reaction (qPCR). RESULTS: In experiments on cultured endometrial cell line, high oestradiol and oxytocin similarly limited the viability of cells. In cultured endometrial explants both also decreased the secretion of prolactin (a marker of decidualization) and augmented endometrial COX-2 activity and formation of PGF2α. Oxytocin antagonist atosiban was confirmed to reverse the above effects, both in the endometrial line and endometrial explants. Addition of atosiban to cultures acted analogously in experiments employing both oxytocin and high oestradiol. CONCLUSIONS: Oxytocin antagonist reversed the effects of high oestradiol and oxytocin on parameters related to endometrial receptivity in conditions mimicking ovarian stimulation. This might point to a novel, endometrium-related mechanism to support embryo implantation achieved by the application of oxytocin antagonist prior to embryo transfer.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Sztachelska M, Ponikwicka-Tyszko D, Sokolowska G, et al. Oxytocin antagonism reverses the effects of high oestrogen levels and oxytocin on decidualization and cyclooxygenase activity in endometrial tissues. Reprod Biomed Online. 2019. PMID: 31548121. doi:10.1016/j.rbmo.2019.06.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。